Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: A multicenter, randomized, double-blind study

Clinical Therapeutics

Volumn 26, Issue 12, 2004, Pages 2026-2033

  Henry, Dan C ^a   Kapral, Dolores ^b   Busman, Todd A ^b   Paris, Maria M ^b  

^a Foothill Family Clinic   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Acute rhinosinusitis; Cefdinir; Levofloxacin

Indexed keywords

ANTIINFECTIVE AGENT; CEFDINIR; LEVOFLOXACIN;

AGE DISTRIBUTION; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SCREENING; DRUG TOLERABILITY; ETHNOLOGY; FACE EDEMA; FEMALE; GASTROENTERITIS; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; NOSE DISEASE; PAIN; POLAND; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RASH; RHINOSINUSITIS; SEX ROLE; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TOOTH PAIN; UNITED STATES; VAGINA CANDIDIASIS;

EID: 14844346535     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2004.12.004     Document Type: Article

References (25)

1. Gwaltney JM Jr Acute community-acquired sinusitis Clin Infect Dis 23 1996 1209 1223
2. series 13 Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments, 1996 Vital Health Stat no 134 1998
3. Ray NF, Baraniuk JN, and Thamer M Healthcare expenditures for sinusitis in 1996: Contributions of asthma, rhinitis, and other airway disorders J Allergy Clin Immunol 103 1999 408 414
4. Physician Drug & Diagnosis Audit and Source Prescription Audit January-December 2002 Verispan, LLC Washington, DC
5. Senior BA, Glaze C, and Benninger MS Use of the Rhinosinusitis Disability Index (RSDI) in rhinologic disease Am J Rhinol 15 2001 15 20
6. [serial online] Bondy J, Berman S, Glazner J, and Lezotte D Direct expenditures related to otitis media diagnoses: Extrapolations from a pediatric Medicaid cohort Pediatrics 105 2000 E72
7. Gwaltney JM Jr Sinusitis Mandell GL Bennett JE Dolin R Principles and Practice of Infectious Diseases 5th ed 2000 Churchill Livingstone Yardley, Pa 676 686
8. [published correction appears in Otolaryngol Head Neck Surg. 2004;130;794-796] Anon JB, Jacobs MR, Poole MD Sinus and Allergy Health Partnership Antimicrobial treatment guidelines for acute bacterial rhinosinusitis Otolaryngol Head Neck Surg 130 Suppl 1 2004 1 45
9. Doern GV, Heilmann KP, and Huynh HK Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995 Antimicrob Agents Chemother 45 2001 1721 1729
10. Hoban D, and Felmingham D The PROTEKT surveillance study: Antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections J Antimicrob Chemother 50 Suppl 1 2002 49 59
11. Rybak MJ Increased bacterial resistance: PROTEKT US--an update Ann Pharmacother 38 Suppl 9 2004 S8 S13
12. Thomsberry C, Sahm DF, and Kelly LJ Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella calarrhalis in the United States: Results from the TRUST Surveillance Program, 1999-2000 Clin Infect Dis 34 Suppl 1 2002 S4 S16
13. Gwaltney JM Jr, Savolainen S, Rivas P Cefdinir Sinusitis Study Group Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis Antimicrob Agents Chemother 41 1997 1517 1520
14. Perry CM, and Scott LJ Cefdinir: A review of its use in the management of mild-to-moderate bacterial infections Drugs 64 2004 1433 1464
15. Dagan R, Klugman KP, Craig WA, and Baquero F Evidence to support the rationale that bacterial eradication in respiratory tract infection is an important aim of antimicrobial therapy J Antimicrob Chemother 47 2001 129 140
16. MacDonald TM, Beardon PH, and McGilchrist MM The risks of symptomatic vaginal candidiasis after oral antibiotic therapy QJ Med 86 1993 419 424
17. Xu J, and Sobel JD Antibiotic-associated vulvovaginal candidiasis Curr Infec Dis Rep 5 2003 481 487
18. Levaquin [package insert] 2004 Ortho-McNeil Pharmaceutical, Inc Philadelphia
19. Omnicef [package insert] 2004 Abbott Laboratories Raritan, NJ
20. Lindbaek M, and Hjortdahl P The clinical diagnosis of acute purulent sinusitis in general practice--a review Br J Gen Pract 52 2002 491 495
21. Young J, Bucher H, and Tschudi P The clinical diagnosis of acute bacterial rhinosinusitis in general practice and its therapeutic consequences J Clin Epidemiol 56 2003 377 384
22. Gehanno P, Beauvillain C, and Bobin S Short therapy with amoxicillin-clavulanate and corticosteroids in acute sinusitis: Results of a multicentre study in adults Scand J Infect Dis 32 2000 679 684
23. Sher LD, McAdoo MA, and Bettis RB A multicenter, randomized, investigator-blinded study of 5- and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis Clin Ther 24 2002 269 281
24. Adelglass J, DeAbate CA, and McElvaine P Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults Otolaryngol Head Neck Surg 120 1999 320 327
25. Lasko B, Lau CY, Saint-Pierre C Canadian Sinusitis Study Group Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: A multicentre, doubleblind, randomized study J Int Med Res 26 1998 281 291